The BÜHLMANN Quantum Blue® Infliximab is the ONLY quantitative rapid test in the market for infliximab that can provide fast, reliable information for infliximab. The test is designed for the selective measurement of infliximab in serum by a sandwich immunoassay.
The BÜHLMANN Quantum Blue® fCAL extended Assay offers an extended standard range of 30 -1000µg/g, offering ability to quantify calprotectin in a wide range of sample concentrations with no dilution required.
The BÜHLMANN Quantum Blue® High Range Assay offers an extended standard range of 100-1800 µg/g and ability to quantify calprotectin in samples with higher concentrations (you can dilute and re-run or report >1800 µg/g).
The Quantum Blue® Product Line is based on lateral flow technology offeringquantitative results within minutes. Check out our Quantum Blue® Calprotectin Assays on our new new microsite: www.calprotectinassays.com! Learn more about calprotectin and find out which assay is best for you!
BUHLMANN Diagnostics Corp (BDC), Amherst NH is the North American affiliate of BÜHLMANN Laboratories AG, a leading worldwide operative manufacturer of ELISA kits, RIA kits, lateral flow assay kits, flow cytometry assay kits and turbidimetric assays kits. Located in a state-of-the-art facility in Southern New Hampshire, the BDC team collectively represents over 100 years of experience in serving both clinical and basic science research laboratories.